300 NORTH CAPITAL, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 194 filers reported holding SEATTLE GENETICS INC in Q2 2014. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
300 NORTH CAPITAL, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q1 2015$789,000
-6.2%
22,299
-14.8%
0.17%
-10.3%
Q4 2014$841,000
-13.5%
26,180
+0.1%
0.19%
-24.8%
Q3 2014$972,000
-53.0%
26,153
-51.6%
0.26%
-49.3%
Q2 2014$2,068,000
-12.4%
54,053
+4.4%
0.51%
-16.8%
Q1 2014$2,360,000
+21.8%
51,763
+6.6%
0.61%
+14.0%
Q4 2013$1,938,000
-12.4%
48,573
-3.8%
0.54%
+4.1%
Q3 2013$2,213,000
+163.5%
50,502
+89.1%
0.52%
+57.8%
Q2 2013$840,00026,7000.33%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders